October 10, 2025

Opinion: When patients refuse cancer treatment

On the “First Opinion Podcast,” an oncologist and a breast cancer survivor discuss the complicated relationship between doctor and cancer patient.

By Torie Bosch


STAT+ | Expedition Therapeutics, a biotech company scouring China for drug candidates, raises $165 million

The funding will be used to advance a drug for the lung condition COPD that was originally developed by Shanghai drugmaker Fosun Pharma.

By Allison DeAngelis


STAT+ | Novo Nordisk to buy Akero Therapeutics, picking up promising MASH drug

The deal, worth $4.7 billion upfront, centers on the drug efruxifermin, which has shown promising results in trials.

By Adam Feuerstein



President Trump and Pfizer CEO Albert Bourla at the White House.
Win McNamee/Getty Images

STAT+ | Pharma companies scramble to make deals with Trump after Pfizer scored White House praise

Pharma companies are hoping to announce deals of their own with President Trump as soon as this week, sources told STAT.

By Daniel Payne


More around STAT

In case you missed it

  • How ultrasound is ushering a new era of surgery-free cancer treatment, BBC
  • Engineered “natural killer” cells could help fight cancer. Similar to CAR-T cells, these cells can be programmed to attack cancer cells, MIT News.
  • Johnson & Johnson ordered to pay $966 million in latest talc lawsuit. The case involves a California woman who died from mesothelioma, a rare cancer, New York Times.

Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Cancer Briefing? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.